Identification of de novo synthesized and relatively older proteins: Accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes

Diabetes

Volumn 59, Issue 10, 2010, Pages 2366-2374

  Jaleel, Abdul ^a,c   Henderson, Gregory C ^a,b   Madden, Benjamin J ^a   Klaus, Katherine A ^a   Morse, Dawn M ^a   Gopala, Srinivas ^a   Nair, K Sreekumaran ^a  

^a MAYO CLINIC   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Chellaram Diabetes Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN LISPRO; LONG ACTING INSULIN; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEAMINATION; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; APOLIPOPROTEIN A-I; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REFERENCE VALUES;

EID: 77957598060     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0371     Document Type: Article

References (46)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820
3. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998;21:1736-1742
4. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-1574
5. Telci A, Cakatay U, Salman S, Satman I, Sivas A. Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 2000;50: 213-223
6. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med 1998;25:369-372
7. Cakatay U, Telci A, Salman S, Satman L, Sivas A. Oxidative protein damage in type I diabetic patients with and without complications. Endocr Res 2000;26:365-379
8. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase- related protein 2, α-enolase and heat shock cognate 71. J Neurochem 2002;82:1524-1532
9. Bojanovski D, Gregg RE, Ghiselli G, Schaefer EJ, Light JA, Brewer HB Jr. Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I. J Lipid Res 1985;26:185-193
10. Ghiselli G, Rohde MF, Tanenbaum S, Krishnan S, Gotto AM Jr. Origin of apolipoprotein A-I polymorphism in plasma. J Biol Chem 1985;260:15662-15668
11. Zannis VI, Breslow JL, Katz AJ. Isoproteins of human apolipoprotein A-I demonstrated in plasma and intestinal organ culture. J Biol Chem 1980; 255:8612-8617
12. Kim SS, Kim MH, Shin BK, Na HJ, Choi JY, Kee MK, Chong SA, Nam MJ. Different isoforms of apolipoprotein AI present heterologous post-translational expression in HIV infected patients. J Proteome Res 2007;6:180-184
13. Yang F, Yin Y, Wang F, Zhang L, Wang Y, Sun S. An altered pattern of liver apolipoprotein A-I isoforms is implicated in male chronic hepatitis B progression. J Proteome Res 2009;9:134-143
14. Mateos-Caceres PJ, Garcia-Mendez A, Lopez FA, Macaya C, Nunez A, Gomez J, Alonso-Org, Carrasco C, Burgos ME, de Andres R, Granizo JJ, Farre J, Rico LA. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004;44:1578-1583
15. McGregor E, Kempster L, Wait R, Gosling M, Dunn MJ, Powell JT. F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol Cell Proteomics 2004;3:115-124
16. Poth AG, Deeth HC, Alewood PF, Holland JW. Analysis of the human casein phosphoproteome by 2-D electrophoresis and MALDI-TOF/TOF MS reveals new phosphoforms. J Proteome Res 2008;7:5017-5027
17. Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, Field E, Schatz CR, Estock MA, Ahmed N, Anderson NG, Steiner S. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004;4:1159-1174
18. Lee C, Tsai Y, Sensibar J, Oliver L, Grayhack JT. Two-dimensional characterization of prostatic acid phosphatase, prostatic specific antigen and prostate binding protein in expressed prostatic fluid. Prostate 1986;9: 135-146
19. Sarioglu H, Lottspeich F, Walk T, Jung G, Eckerskorn C. Deamidation as a widespread phenomenon in two-dimensional polyacrylamide gel electrophoresis of human blood plasma proteins. Electrophoresis 2000;21:2209-2218
20. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-755
21. Karakelides H, Asmann YW, Bigelow ML, Short KR, Dhatariya K, Coenen-Schimke J, Kahl J, Mukhopadhyay D, Nair KS. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 2007;56:2683-2689
22. Jaleel A, Klaus K, Morse DM, Karakelides H, Ward LE, Irving BA, Nair KS. Differential effects of insulin deprivation and systemic insulin treatment on plasma protein synthesis in type 1 diabetic people. Am J Physiol Endocrinol Metab 2009;297:E889-E897
23. Jaleel A, Short KR, Asmann YW, Klaus KA, Morse DM, Ford GC, Nair KS. In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins. Am J Physiol Endocrinol Metab 2008;295:E1255-E1268
24. Ford GC, Cheng KN, Halliday D. Analysis of [1-C-13]leucine and [c-13]KIC in plasma by capillary gas chromatography/mass spectrometry in protein turnover studies. Biomed Mass Spectrom 1985;12:432-436
25. Schwenk WF, Berg PJ, Beaufrère B, Miles JM, Haymond MW. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem 1984;141:101-109
26. Wu AL, Windmueller HG. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem 1979;254:7316-7322
27. Ghiselli G, Gotto AM Jr, Tanenbaum S, Sherrill BC. Proapolipoprotein A-I conversion kinetics in vivo in human and in rat. Proc Natl Acad Sci U S A 1985;82:874-878
28. Ghiselli G, Bradley WA, Gotto AM Jr, Sherrill BC. Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I. Biochem Biophys Res Commun 1983;116:704-711
29. Yan L-J, Sohal RS. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci U S A 1998;95:12896-12901
30. Yan L-J, Levine RL, Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 1997;94:11168-11172
31. Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci U S A 1997;94:6132-6137
32. Chavous DA, Jackson FR, O'Connor CM. Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc Natl Acad Sci U S A 2001;98:14814-14818
33. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002;33:562-571
34. Watanabe A, Takio K, Ihara Y. Deamidation and isoaspartate formation in smeared τ in paired helical filaments. Unusual properties of the microtubule-binding domain of τ. J Biol Chem 1999;274:7368-7378
35. Sharma KK, Santhoshkumar P. Lens aging: effects of crystallins. Biochim Biophys Acta 2009;1790:1095-1108
36. Takemoto L. Deamidation of Asn-143 of gamma S crystallin from protein aggregates of the human lens. Curr Eye Res 2001;22:148-153
37. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabete Metab 2005;31:551-557
38. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled type I (insulin-dependent) diabetic patients. Diabetologia 1984; 27:13-16
39. Owen OE, Trapp VE, Recihard GA Jr, Mozzoli MA, Boden G. Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes 1980;29:365-372
40. Pehling GB, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 1984;74:985-991
41. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983;25:400-403
42. Orpiszewski J, Schormann N, Kluve-Beckerman B, Liepnieks JJ, Benson MD. Protein aging hypothesis of Alzheimer disease. FASEB J 2000;14:1255-1263
43. Radak Z, Takahashi R, Kumiyama A, Nakamoto H, Ohno H, Ookawara T, Goto S. Effect of aging and late onset dietary restriction on antioxidant enzymes and proteasome activities, and protein carbonylation of rat skeletal muscle and tendon. Exp Gerontol 2002;37:1423-1430
44. Nair KS, Ford GC, Halliday D. Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulindeprived type I diabetic patients. Metabolism 1987;36:491-495
45. Pacy PJ, Nair KS, Ford C, Halliday D. Failure of insulin infusion to stimulate fractional muscle protein synthesis in type 1 diabetic patients - anabolic effect of insulin and decreased proteolysis. Diabetes 1989;38:618-624
46. De Feo P, Gan Gaisano M, Haymond MW. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 1991;88:833-840